Tilia Fiduciary Partners, Inc. Pfizer Inc Transaction History

Tilia Fiduciary Partners, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 13, 2023	BUY	$36.12 - $41.79 $60,500 - $69,998	1,675 Added 62.38%	4,360 $159,000
Q1 2023 May 10, 2023	SELL	$39.39 - $51.28 $22,215 - $28,921	-564 Reduced 17.36%	2,685 $109,000
Q4 2022 Feb 10, 2023	SELL	$41.75 - $54.5 $1,461 - $1,907	-35 Reduced 1.07%	3,249 $166,000
Q3 2022 Oct 26, 2022	SELL	$43.76 - $53.42 $4,507 - $5,502	-103 Reduced 3.04%	3,284 $138,000
Q2 2022 Aug 01, 2022	BUY	$46.53 - $55.17 $139 - $165	3 Added 0.09%	3,387 $176,000
Q1 2022 Apr 18, 2022	BUY	$45.75 - $56.69 $19,581 - $24,263	428 Added 14.48%	3,384 $175,000
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $122,141 - $181,055	2,956 New	2,956 $175,000

3,267

3.73B

74.2M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Tilia Fiduciary Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Tilia Fiduciary Partners, Inc. with notifications on news.